OraSure Technologies to Provide OraQuick In-Home HIV Tests for CDC Program








MT Newswires 2022

All news about ORASURE TECHNOLOGIES, INC.

Analyst Recommendations on ORASURE TECHNOLOGIES, INC.

Sales 2022 329 M

Net income 2022 -34,1 M

Net cash 2022 153 M

P/E ratio 2022 -8,34x
Yield 2022
Capitalization 289 M
289 M
EV / Sales 2022 0,41x
EV / Sales 2023 0,89x
Nbr of Employees 785
Free-Float 96,1%

Chart ORASURE TECHNOLOGIES, INC.



Duration :


Period :




OraSure Technologies, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends ORASURE TECHNOLOGIES, INC.

Short Term Mid-Term Long Term
Trends Bullish Neutral Bearish




Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 3,98 $
Average target price 5,33 $
Spread / Average Target 34,0%




Source link

Ozinize
Logo
Shopping cart